vs
ACADIA PHARMACEUTICALS INC（ACAD）与Axos Financial, Inc.（AX）财务数据对比。点击上方公司名可切换其他公司
Axos Financial, Inc.的季度营收约是ACADIA PHARMACEUTICALS INC的1.5倍（$392.2M vs $268.1M），Axos Financial, Inc.净利率更高（31.8% vs 1.4%，领先30.4%），过去两年Axos Financial, Inc.的营收复合增速更高（16.1% vs 5.3%）
阿卡迪亚制药是一家总部位于美国加利福尼亚州圣地亚哥德尔马地区的生物制药企业，专注于中枢神经系统相关疾病治疗药物的研发、生产与商业化，致力于为全球患者提供创新的临床治疗方案。
Axos Financial是总部位于美国内华达州拉斯维加斯的银行控股公司，旗下拥有直销银行Axos Bank，同时提供注册投资顾问服务及电子交易平台，深耕数字化金融赛道，可为用户提供多元便捷的金融服务解决方案。
ACAD vs AX — 直观对比
营收规模更大
AX
是对方的1.5倍
$268.1M
净利率更高
AX
高出30.4%
1.4%
两年增速更快
AX
近两年复合增速
5.3%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $268.1M | $392.2M |
| 净利润 | $3.6M | $124.7M |
| 毛利率 | — | — |
| 营业利润率 | -1.7% | — |
| 净利率 | 1.4% | 31.8% |
| 营收同比 | 9.7% | — |
| 净利润同比 | — | 18.5% |
| 每股收益（稀释后） | $0.02 | $2.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACADAX
| Q1 26 | $268.1M | $392.2M | ||
| Q4 25 | $284.0M | $385.1M | ||
| Q3 25 | $278.6M | $323.4M | ||
| Q2 25 | $264.6M | $321.4M | ||
| Q1 25 | $244.3M | $308.8M | ||
| Q4 24 | $259.6M | $307.9M | ||
| Q3 24 | $250.4M | $320.7M | ||
| Q2 24 | $242.0M | $290.9M |
净利润ACADAX
| Q1 26 | $3.6M | $124.7M | ||
| Q4 25 | $273.6M | $128.4M | ||
| Q3 25 | $71.8M | $112.4M | ||
| Q2 25 | $26.7M | $110.7M | ||
| Q1 25 | $19.0M | $105.2M | ||
| Q4 24 | $143.7M | $104.7M | ||
| Q3 24 | $32.8M | $112.3M | ||
| Q2 24 | $33.4M | $104.9M |
毛利率ACADAX
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
营业利润率ACADAX
| Q1 26 | -1.7% | — | ||
| Q4 25 | 6.1% | 45.6% | ||
| Q3 25 | 12.8% | 46.3% | ||
| Q2 25 | 12.2% | 48.5% | ||
| Q1 25 | 7.9% | 47.9% | ||
| Q4 24 | 59.1% | 48.8% | ||
| Q3 24 | 12.6% | 49.6% | ||
| Q2 24 | 12.6% | 49.6% |
净利率ACADAX
| Q1 26 | 1.4% | 31.8% | ||
| Q4 25 | 96.3% | 33.3% | ||
| Q3 25 | 25.8% | 34.7% | ||
| Q2 25 | 10.1% | 34.4% | ||
| Q1 25 | 7.8% | 34.1% | ||
| Q4 24 | 55.4% | 34.0% | ||
| Q3 24 | 13.1% | 35.0% | ||
| Q2 24 | 13.8% | 36.0% |
每股收益（稀释后）ACADAX
| Q1 26 | $0.02 | $2.15 | ||
| Q4 25 | $1.61 | $2.22 | ||
| Q3 25 | $0.42 | $1.94 | ||
| Q2 25 | $0.16 | $1.89 | ||
| Q1 25 | $0.11 | $1.81 | ||
| Q4 24 | $0.86 | $1.80 | ||
| Q3 24 | $0.20 | $1.93 | ||
| Q2 24 | $0.20 | $1.75 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $3.1B |
| 总资产 | $1.6B | $29.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACADAX
| Q1 26 | — | — | ||
| Q4 25 | $177.7M | $1.0B | ||
| Q3 25 | $258.0M | $2.6B | ||
| Q2 25 | $253.6M | $1.9B | ||
| Q1 25 | $217.7M | $2.0B | ||
| Q4 24 | $319.6M | $2.4B | ||
| Q3 24 | $155.1M | $2.6B | ||
| Q2 24 | $177.1M | $2.0B |
总债务ACADAX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $312.7M | ||
| Q1 25 | — | $377.4M | ||
| Q4 24 | — | $358.7M | ||
| Q3 24 | — | $313.5M | ||
| Q2 24 | — | $325.7M |
股东权益ACADAX
| Q1 26 | — | $3.1B | ||
| Q4 25 | $1.2B | $2.9B | ||
| Q3 25 | $917.3M | $2.8B | ||
| Q2 25 | $822.4M | $2.7B | ||
| Q1 25 | $765.2M | $2.6B | ||
| Q4 24 | $732.8M | $2.5B | ||
| Q3 24 | $577.2M | $2.4B | ||
| Q2 24 | $516.7M | $2.3B |
总资产ACADAX
| Q1 26 | $1.6B | $29.2B | ||
| Q4 25 | $1.6B | $28.2B | ||
| Q3 25 | $1.3B | $27.4B | ||
| Q2 25 | $1.2B | $24.8B | ||
| Q1 25 | $1.1B | $24.0B | ||
| Q4 24 | $1.2B | $23.7B | ||
| Q3 24 | $976.9M | $23.6B | ||
| Q2 24 | $914.1M | $22.9B |
负债/权益比ACADAX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.14× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACAD
暂无分部数据
AX
| Net Interest Income | $306.3M | 78% |
| Noninterest Income | $86.0M | 22% |
